Metachronous immune-related adverse events involving type 1 diabetes and isolated adrenocorticotropic hormone deficiency associated with pembrolizumab monotherapy for metastatic head and neck cancer: a case report

Metachronous immune-related adverse events involving type 1 diabetes and isolated adrenocorticotropic hormone deficiency associated with pembrolizumab monotherapy for metastatic head and neck cancer: a case report

Abstract Background Immune checkpoint inhibitors might cause immune-related adverse events that are still largely unknown. Case presentation An 80-year-old Asian female was diagnosed with cervical lymph node metastasis from lip cancer (cT1N0M0) and underwent right cervical neck dissection. Subsequen...

Full description

Bibliographic Details
Main Authors: Hiroaki Iijima, Akihiro Sakai, Koji Ebisumoto, Mayu Yamauchi, Takanobu Teramura, Aritomo Yamazaki, Toshihide Inagi, Kenji Okami
Format: Article
Language:English
Published: BMC 2023-09-01
Series:Journal of Medical Case Reports
Subjects:
Immune checkpoint inhibitors
Head and neck cancer
Recurrence/metastasis
Diabetic ketoacidosis
Pituitary
Online Access:https://doi.org/10.1186/s13256-023-04106-6

Internet

https://doi.org/10.1186/s13256-023-04106-6

Similar Items